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Giant gastrointestinal stromal tumor of the esophagus presenting
with dyspnea
Ahmet Basoglu, MD,a Ekrem Kaya, MD,b Burain Celık, MD,a and Levent Yıldız, MD,c Samsun and Bursa, Turkey
Gastrointestinal stromal tumors (GISTs) are rare neo-plasms thought to arise from mesenchymal cellsof the gastrointestinal tract. These tumors demon-strate a pathobiology and clinical behavior different
from those of smooth muscle and Schwann cell tumors.1 GISTs
account for 0.1% to 3% of all tumors in the gastrointesti-
nal tract. Two thirds of these tumors arise from the stomach,
25% arise from the small intestine, and 5% arise from the
esophagus.2
We describe a case of giant GIST of the esophagus that com-
pressed the right main bronchus and caused dyspnea.
Clinical Summary
A 33-year-old woman was admitted to our hospital with a 6-year
history of dyspnea and 2-year history of dysphagia and back pain.
She had been treated for asthma for 6 years. On admission, chest
radiograph showed a widened mediastinum.
Esophagogram showed a dilated thoracic esophagus and irreg-
ular mucosa in two thirds of the thoracic esophagus. Chest com-
puted tomography revealed massive circumferential thickening of
the esophageal wall extending from the level of the thoracic inlet
to the cardia of the stomach. The giant mass compressed the right
main bronchus (Figure 1).
A mucosal ulceration 33 cm from the incisors and external com-
pression were conﬁrmed by esophagoscopy. Endoscopic ultrasonog-
raphy was undertaken, which conﬁrmed circumferentail thickening of
the esophageal wall 6 to 8 cm along the thoracic esophagus.
Proximal gastrectomy, subtotal esophagectomy, and esophago-
gastrostomy were performed through the abdominothoracic ap-
proach. The tumor weighed 2800 g and was 27 cm long (Figure 2).
The postoperative course was uncomplicated, and the patient was
discharged on the 12th postoperative day. The patient has been
doing well with no recurrence 3 years after the operation.
On histopathologic examination, we observed a tumoral mass
in the esophageal wall between the submucosal and subserosal
layer. We diagnosed this tumor as a GIST of the esophagus. The
tumor was composed of spindle cells with the following features:
mitotic count, 3 to 5/50 high-power ﬁeld; CD117 staining, 10% to
50%/; CD34 staining, 10% to 50%/.
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Figure 1. A, Esophagogram shows large, irreg-
ular intramural mass. B and D, Computed to-
mography (CT) scan shows luminal dilatation
and wall thickening. C, Giant mass compresses
the right main bronchus.
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Discussion
GISTs were previously thought to be smooth muscle neoplasms, and
most were classiﬁed as leiomyoma or leiomyosarcoma. With the
advent of immunohistochemistry and electron microscopy, it became
apparent that GISTs might have myogenic features, neural attributes,
or characteristics of both muscle and nerve. Immunohistochemically,
the tumor cells are positive for CD117 and CD34.2,3 The majority of
GISTs occur in the subdiaphragmatic gastrointestinal tract, but a small
number of cases have been reported in the esophagus.1,2
Symptoms usually depend on tumor size and location. Dyspha-
gia is the most common symptom. The other symptoms include
retrosternal discomfort, dyspepsia, and vomiting.1,4 In our case,
the tumor was too large and compressed the right main bronchus.
To our knowledge, this is the ﬁrst encounter with a case of giant
GIST presenting with dyspnea.
GISTs occur in the older patient population, and the majority of
them are benign (60%-80%). The most consistent prognostic factors
are mitotic count (5/50 high-power ﬁeld) and tumor size (5 cm).
These tumors seem to be resistant to chemoradiation. En bloc surgical
excision is the treatment of choice of these tumors.1,2,5
It is likely that our patient has a rare case of giant esophageal
tumor caused by dyspnea. Because of the lack of any effective
alternative therapies, surgical resection should be considered for
all patients with GISTs.
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Figure 2. A, Tumor invades the esophagus and cardia. B, Re-
sected tumor.
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